Search - tctmd.com

Displaying 321 - 340 of 510

Sort: Relevancy | Date

Presentation TCT 2014

A Novel Drug-Coated Scoring Balloon for the Treatment of Coronary In-Stent Restenosis: One Year Results of the PATENT-C First-in-Human Trial

Presenter: Bruno Scheller

September 16, 2014

Presentation TCT 2014

Novel Patient-based Finite Element Simulation Framework To Evaluate Fatigue Resistance Of Coronary Stent Design

Presenter: Peter Mortier

September 16, 2014

Presentation TCT 2014

TCT 599: Final Procedural, 30-Day and 6-Month Angiographic, Clinical, and OCT Outcomes from the DIRECT II Trial Using the Svelte Integrated Delivery System with Enzymatic Bioabsobable Sirolimus Coating

Presenter: Marie-Claude Morice, Giulio G. Stefanini, Pedro A. Lemos, Stefan Verheye

September 15, 2014

Presentation TCT 2014

Is Pro-healing a Valid Concept? The Sirolimus-Endothelial Progenitor Cell Antibody Combo Technology

Presenter: Marie-Claude Morice, Giulio G. Stefanini, Pedro A. Lemos, Michael Haude

September 15, 2014

Presentation TCT 2014

Novolimus-Eluting from a Bioabsorbable Polymer: Latest Update from EXCELLA II

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Stefan Verheye

September 15, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

Presentation TCT 2014

Acute Coronary Syndromes (Including STEMI)

Presenter: Azeem Latib, Ron Waksman, Ronald Caputo, Thomas A. Ischinger, Bruno Scheller

September 13, 2014

Presentation TCT 2014

Small Vessel, Diabetic, and Diffuse Disease

Presenter: Azeem Latib, Ron Waksman, Ronald Caputo, Thomas A. Ischinger, Paul JL Ong

September 13, 2014

Presentation TCT 2014

Bifurcations: Technical Approach and Clinical Results

Presenter: Azeem Latib, Ron Waksman, Ronald Caputo, Thomas A. Ischinger, Kenneth Chin

September 13, 2014

Presentation TCT 2014

DCB Plus Provisional Scaffold (BRS): Technique and Clinical Results

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Azeem Latib

September 13, 2014

Presentation TCT 2014

DCB Plus Adjunctive Stenting: Technique and Clinical Results

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Jochen Wöhrle

September 13, 2014

Presentation TCT 2014

DCB Only Followed by Provisional Stenting: Insights from BASKET-SMALL 2 Trial

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Raban Jeger

September 13, 2014

Presentation TCT 2014

Technique Strategy Selection: A Critical Review of International Consensus Group Position Papers

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Sahil A. Parikh

September 13, 2014

Presentation TCT 2014

DCB is a Useful Ancillary Tool but Unlikely to Become a Work-Horse Technology!

Presenter: Antonio Colombo

September 13, 2014

Presentation TCT 2014

The DCB-Only Approach Is Feasible: The Real Promise to Leave Nothing Behind!

Presenter: Franz X. Kleber

September 13, 2014

Presentation TCT 2014

DCB ONLY and Vascular Restoration: Insights from Intracoronary OCT Human Studies

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Tudor C Poerner

September 13, 2014

Presentation ESC 2014

Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary revascularization

Presenter: Thomas Pilgrim

September 01, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Daily News

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Todd Neale

August 22, 2014

News Daily News

El Andamiaje Bioabsorbible tiene un Buen Rendimiento aunque Preocupa la Trombosis

Todd Neale

July 24, 2014

Advertisement

A Novel Drug-Coated Scoring Balloon for the Treatment of Coronary In-Stent Restenosis: One Year Results of the PATENT-C First-in-Human Trial

Novel Patient-based Finite Element Simulation Framework To Evaluate Fatigue Resistance Of Coronary Stent Design

TCT 599: Final Procedural, 30-Day and 6-Month Angiographic, Clinical, and OCT Outcomes from the DIRECT II Trial Using the Svelte Integrated Delivery System with Enzymatic Bioabsobable Sirolimus Coating

Is Pro-healing a Valid Concept? The Sirolimus-Endothelial Progenitor Cell Antibody Combo Technology

Novolimus-Eluting from a Bioabsorbable Polymer: Latest Update from EXCELLA II

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Acute Coronary Syndromes (Including STEMI)

Small Vessel, Diabetic, and Diffuse Disease

Bifurcations: Technical Approach and Clinical Results

DCB Plus Provisional Scaffold (BRS): Technique and Clinical Results

DCB Plus Adjunctive Stenting: Technique and Clinical Results

DCB Only Followed by Provisional Stenting: Insights from BASKET-SMALL 2 Trial

Technique Strategy Selection: A Critical Review of International Consensus Group Position Papers

DCB is a Useful Ancillary Tool but Unlikely to Become a Work-Horse Technology!

The DCB-Only Approach Is Feasible: The Real Promise to Leave Nothing Behind!

DCB ONLY and Vascular Restoration: Insights from Intracoronary OCT Human Studies

Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary revascularization

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

El Andamiaje Bioabsorbible tiene un Buen Rendimiento aunque Preocupa la Trombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content